In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses

We evaluated three commercial trivalent inactivated vaccines (TIVs) from the 2007–2008 season in terms of their ability to elicit in vitro T cell responses. T cell- mediated immunity may offer a more cross- reactive vaccine approach for the prevention of pandemic or epidemic influenza. Human cytotox...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Co, Mary Dawn T., Orphin, Laura, Cruz, John, Pazoles, Pamela, Green, Karin M., Potts, James, Leporati, Anita M., Babon, Jenny Aurielle B., Evans, James E., Ennis, Francis A., Terajima, Masanori
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2813682/
https://ncbi.nlm.nih.gov/pubmed/18977404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.09.092
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires